Kexing Biopharm Takes a Significant Step Forward in Promoting the Integration of Industry, Academia, Research, and Application

Article source：Kexing BiopharmOct 28,2025View： 52

Amid a national focus on pharmaceutical innovation and the acceleration of China’s Healthy Nation initiative, Kexing Biopharm has taken a strategic leap forward in advancing the integrated development of industry, academia, research, and application. This achievement reflects the company’s long-standing commitment to technological innovation and marks a new milestone in building a collaborative ecosystem for biopharmaceutical advancement.

Guided by its mission—“Lean manufacturing, precise medication, safeguarding health”—Kexing Biopharm has continually built a market-driven, enterprise-led innovation system. By aligning fundamental research with clinical application and industrial production, the company has developed a closed-loop innovation model that covers the entire pharmaceutical value chain: from laboratory breakthroughs to large-scale manufacturing, and finally to real-world clinical use.

Over the years, Kexing Biopharm has established deep partnerships with leading universities, research institutes, and hospitals both domestically and internationally. Focusing on areas such as tumor immunotherapy, biologics, chronic disease management, and recombinant protein drugs, these collaborations have yielded a growing number of scientific breakthroughs and patentable technologies.

In practice, Kexing Biopharm has pioneered multiple collaboration models for integrated development. These include the establishment of in-house research institutes, joint laboratories, and project-based incentive mechanisms that empower teams to tackle specific technical challenges. Such mechanisms break down traditional silos and foster efficient exchanges of knowledge, technology, and talent across institutions.

Recognizing that innovation thrives on people, Kexing Biopharm has made talent cultivation a strategic priority. The company has built a robust talent pipeline by combining internal development programs with external recruitment. Today, its R&D team includes a diverse mix of PhD holders, experienced scientists, and senior engineers, all of whom contribute to sustaining the company's leading edge in innovation.

Looking ahead, Kexing Biopharm remains committed to deepening the integration of industry, academia, research, and application. Kexing will continue to foster high-level collaboration across the pharmaceutical value chain, working closely with academic institutions, industrial partners, clinical centers, and government agencies. With an unwavering focus on excellence, vision, and execution, Kexing Biopharm aims to transform China's pharmaceutical innovation from rapid growth to high-quality development.